Empfohlen
Weitere ähnliche Inhalte
Ähnlich wie Zeus Photobiotics
Ähnlich wie Zeus Photobiotics (20)
Kürzlich hochgeladen
Kürzlich hochgeladen (20)
Zeus Photobiotics
- 2. Mission To be the leading provider of laser technology for better medical and veterinarian practices
- 3. Medical Benefits Medical laser instruments can be effectively used for Tissue debridement Hemostasis Tissue disinfecting Reduce pain Accelerate Wound Closure
- 4. Vertical Segments Medical laser instruments can be effectively used for Chronic Diabetic Foot Ulcers Chronic Skin Ulcers Chronic Wounds in Horses
- 5. Vertical: Diabetic Foot Ulcers Existing treatment modalities have several problems: Long-term use of antibiotics makes bacteria more resistant, rendering antibiotic treatment to be less effective. Tissue debridement with a scalpel removes excess healthy tissue. Hemostasis is difficult to achieve in diabetic patients due to poor wound healing.
- 6. Growth Rate of Diabetes
- 7. DFU Wound Care Management market: $1.5B DFU Wound Care Management Market CAGR: 39.9% Global Wound Healing Market Revenue is $17.3 Billion https://healthcare.globaldata.com/media-center/press-releases/pharmaceuticals/diabetic-foot-ulcer-market-in-rapid-race-to-reach-more-than-15-billion-value
- 8. Zeus Photobiotics’ Solution A medical laser that can be used to treat infected diabetic foot ulcers Features: Better wound healing with less discomfort Disinfect tissue without the use of antibiotics Precision tissue removal
- 9. Stakeholder’s Motivation Insurances Reduce costs Hospitals Reduce costs Improve patient outcomes Patients Less painful Decrease reliance on antibiotics Healthcare Providers Easy to use Better results
- 10. Market Strategy Hospitals & Outpatient Clinics Patients ZEUS PhotobioticsInsurance Companies $$$ $ $$
- 11. Development Plan
- 12. Prototype Development FDA Clinical Trials Phase 1 FDA Clinical Trials Phase 2 Outcome Analysis Investment Grants Revenue/ Customer Acquisition Engineering Development Timeline Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
- 13. Budget Plan
- 14. Budget Plan: 2016-2017 2016: $50-100K Q1-Q2: $10-20K Pre Seed Investment: $30-40k $10-20k Proof of Concept Research File Provisional IP: $500 Q3-Q4: $10-20K FDA 510(k) Continue Prototype Engineering Research SBIR Grant Filing 2017: Seed investment $10-15 Million $5-10 million for FDA Clinical Trial Studies $5 million for Marketing
- 15. Long Term Vision Patients can walk with healthy feet
- 16. Competitors
- 17. Lasers in Wound Healing
- 18. Team Leon Chung Co-Founder UCSF Graduate Student 3+ years of Healthcare Sam Pandey Co-Founder USF Graduate Student 3+ Years Business Dev.
- 19. Diabetic Foot Ulcer Treatment (DFU’s) https://www.youtube.com/watch?v=5UkXnEjv7x4 Global Data: DFU Diabetic Foot Ulcer Market in Rapid Race to Reach More than $1.5 Billion Value. (n.d.). Retrieved September 14, 2016, from https://healthcare.globaldata.com/media-center/press-releases/pharmaceuticals/diabetic-foot-ulcer-market- in-rapid-race-to-reach-more-than-15-billion-value National Institute on Health Role of Low Level Laser Therapy in NeuroRehabilitation;PM R. 2010 December ; 2(12 Suppl 2): S292– S305. doi:10.1016/j.pmrj.2010.10.013. References
Hinweis der Redaktion
- Use testimonies to get emotional
- Use testimonies to get emotional
- Use testimonies to get emotional
- Use testimonies to get emotional
- Hospitals and Clinics purchase directly from our sales team. Uplift economically Hospital → reduce OR, reduce time spent in hospital, reduce Insurance companies → reduce patient medical bill for amputations Patients Downgrade economically Surgeons who does the amputation Drug companies → Potentially reduce the need for antibio
- Use testimonies to get emotional